Physiologically Based Pharmacokinetic (PBPK) Approach to Discern Potential Population Differences in Patients with Refractory Solid Tumors and Healthy Subjects: The Effects of Fedratinib on CYP3A4 Substrate Midazolam
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS(2014)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要